Molecular and immunologic analysis of laryngeal squamous cell carcinoma in smokers and non-smokers

Ian James Malm, Lisa M. Rooper, Justin Avery Bishop, Selmin Karatayli Ozgursoy, Alexander T. Hillel, Lee M. Akst, Simon R. Best

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Laryngeal squamous cell carcinoma (LSCC) is strongly associated with tobacco use, but recent reports suggest an increasing incidence of LSCC in patients without traditional risk factors, suggesting an alternative etiology of tumorigenesis. The purpose of this study is to characterize this non-smoking population and to compare immunohistochemical markers in tumor specimens from non-smokers and smokers with LSCC. Methods: A retrospective chart review of patients with LSCC at Johns Hopkins Hospital (JHH) was performed. A tissue microarray (TMA) was constructed with tumor specimen from non-smokers with stage and age-matched smokers and stained for a variety of immunologic and molecular targets. Results: In the JHH cohort of 521 patients, 12% (n = 63) were non-smokers. Non-smokers were more likely to be <45 years old at time of diagnosis (OR 4.13, p = 0.001) and to have glottic tumors (OR 2.46, p = 0.003). The TMA was comprised of tumors from 34 patients (14 non-smokers, 20 smokers). Only 2 patients (6%) were human-papillomavirus (HPV) positive by high-risk RNA in situ hybridization (ISH). There was no correlation between smoking status and p16 (p = 0.36), HPV-ISH positivity (p = 0.79), phosphatase and tensin homolog (PTEN, p = 0.91), p53 (p = 0.14), or programmed death-ligand 1 (PD-L1, p = 0.27) expression. Conclusions: Non-smokers with LSCC are more likely to be younger at the time of diagnosis and have glottic tumors than smokers with LSCC. In TMA analysis of stage and age-matched specimens from smoker and non-smokers with LSCC, the pattern of expression for common molecular and immunologic markers is similar. Further, HPV does not appear to be a major causative etiology of LSCC in either smokers or non-smokers in our cohort of patients.

Fingerprint

Squamous Cell Carcinoma
Tongue
In Situ Hybridization
Neoplasms
Tissue Array Analysis
Human papillomavirus 6
Tobacco Use
Tumor Biomarkers
Phosphoric Monoester Hydrolases
Carcinogenesis
Biomarkers
Smoking
RNA
Ligands
Incidence
Population

Keywords

  • HPV
  • Immunohistochemistry
  • Laryngeal cancer
  • Squamous cell carcinoma

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Molecular and immunologic analysis of laryngeal squamous cell carcinoma in smokers and non-smokers. / Malm, Ian James; Rooper, Lisa M.; Bishop, Justin Avery; Ozgursoy, Selmin Karatayli; Hillel, Alexander T.; Akst, Lee M.; Best, Simon R.

In: American Journal of Otolaryngology - Head and Neck Medicine and Surgery, 01.01.2018.

Research output: Contribution to journalArticle

Malm, Ian James ; Rooper, Lisa M. ; Bishop, Justin Avery ; Ozgursoy, Selmin Karatayli ; Hillel, Alexander T. ; Akst, Lee M. ; Best, Simon R. / Molecular and immunologic analysis of laryngeal squamous cell carcinoma in smokers and non-smokers. In: American Journal of Otolaryngology - Head and Neck Medicine and Surgery. 2018.
@article{0c5dc4ce118c4ea589bde0d554460bb5,
title = "Molecular and immunologic analysis of laryngeal squamous cell carcinoma in smokers and non-smokers",
abstract = "Background: Laryngeal squamous cell carcinoma (LSCC) is strongly associated with tobacco use, but recent reports suggest an increasing incidence of LSCC in patients without traditional risk factors, suggesting an alternative etiology of tumorigenesis. The purpose of this study is to characterize this non-smoking population and to compare immunohistochemical markers in tumor specimens from non-smokers and smokers with LSCC. Methods: A retrospective chart review of patients with LSCC at Johns Hopkins Hospital (JHH) was performed. A tissue microarray (TMA) was constructed with tumor specimen from non-smokers with stage and age-matched smokers and stained for a variety of immunologic and molecular targets. Results: In the JHH cohort of 521 patients, 12{\%} (n = 63) were non-smokers. Non-smokers were more likely to be <45 years old at time of diagnosis (OR 4.13, p = 0.001) and to have glottic tumors (OR 2.46, p = 0.003). The TMA was comprised of tumors from 34 patients (14 non-smokers, 20 smokers). Only 2 patients (6{\%}) were human-papillomavirus (HPV) positive by high-risk RNA in situ hybridization (ISH). There was no correlation between smoking status and p16 (p = 0.36), HPV-ISH positivity (p = 0.79), phosphatase and tensin homolog (PTEN, p = 0.91), p53 (p = 0.14), or programmed death-ligand 1 (PD-L1, p = 0.27) expression. Conclusions: Non-smokers with LSCC are more likely to be younger at the time of diagnosis and have glottic tumors than smokers with LSCC. In TMA analysis of stage and age-matched specimens from smoker and non-smokers with LSCC, the pattern of expression for common molecular and immunologic markers is similar. Further, HPV does not appear to be a major causative etiology of LSCC in either smokers or non-smokers in our cohort of patients.",
keywords = "HPV, Immunohistochemistry, Laryngeal cancer, Squamous cell carcinoma",
author = "Malm, {Ian James} and Rooper, {Lisa M.} and Bishop, {Justin Avery} and Ozgursoy, {Selmin Karatayli} and Hillel, {Alexander T.} and Akst, {Lee M.} and Best, {Simon R.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.amjoto.2018.11.009",
language = "English (US)",
journal = "American Journal of Otolaryngology - Head and Neck Medicine and Surgery",
issn = "0196-0709",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Molecular and immunologic analysis of laryngeal squamous cell carcinoma in smokers and non-smokers

AU - Malm, Ian James

AU - Rooper, Lisa M.

AU - Bishop, Justin Avery

AU - Ozgursoy, Selmin Karatayli

AU - Hillel, Alexander T.

AU - Akst, Lee M.

AU - Best, Simon R.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Laryngeal squamous cell carcinoma (LSCC) is strongly associated with tobacco use, but recent reports suggest an increasing incidence of LSCC in patients without traditional risk factors, suggesting an alternative etiology of tumorigenesis. The purpose of this study is to characterize this non-smoking population and to compare immunohistochemical markers in tumor specimens from non-smokers and smokers with LSCC. Methods: A retrospective chart review of patients with LSCC at Johns Hopkins Hospital (JHH) was performed. A tissue microarray (TMA) was constructed with tumor specimen from non-smokers with stage and age-matched smokers and stained for a variety of immunologic and molecular targets. Results: In the JHH cohort of 521 patients, 12% (n = 63) were non-smokers. Non-smokers were more likely to be <45 years old at time of diagnosis (OR 4.13, p = 0.001) and to have glottic tumors (OR 2.46, p = 0.003). The TMA was comprised of tumors from 34 patients (14 non-smokers, 20 smokers). Only 2 patients (6%) were human-papillomavirus (HPV) positive by high-risk RNA in situ hybridization (ISH). There was no correlation between smoking status and p16 (p = 0.36), HPV-ISH positivity (p = 0.79), phosphatase and tensin homolog (PTEN, p = 0.91), p53 (p = 0.14), or programmed death-ligand 1 (PD-L1, p = 0.27) expression. Conclusions: Non-smokers with LSCC are more likely to be younger at the time of diagnosis and have glottic tumors than smokers with LSCC. In TMA analysis of stage and age-matched specimens from smoker and non-smokers with LSCC, the pattern of expression for common molecular and immunologic markers is similar. Further, HPV does not appear to be a major causative etiology of LSCC in either smokers or non-smokers in our cohort of patients.

AB - Background: Laryngeal squamous cell carcinoma (LSCC) is strongly associated with tobacco use, but recent reports suggest an increasing incidence of LSCC in patients without traditional risk factors, suggesting an alternative etiology of tumorigenesis. The purpose of this study is to characterize this non-smoking population and to compare immunohistochemical markers in tumor specimens from non-smokers and smokers with LSCC. Methods: A retrospective chart review of patients with LSCC at Johns Hopkins Hospital (JHH) was performed. A tissue microarray (TMA) was constructed with tumor specimen from non-smokers with stage and age-matched smokers and stained for a variety of immunologic and molecular targets. Results: In the JHH cohort of 521 patients, 12% (n = 63) were non-smokers. Non-smokers were more likely to be <45 years old at time of diagnosis (OR 4.13, p = 0.001) and to have glottic tumors (OR 2.46, p = 0.003). The TMA was comprised of tumors from 34 patients (14 non-smokers, 20 smokers). Only 2 patients (6%) were human-papillomavirus (HPV) positive by high-risk RNA in situ hybridization (ISH). There was no correlation between smoking status and p16 (p = 0.36), HPV-ISH positivity (p = 0.79), phosphatase and tensin homolog (PTEN, p = 0.91), p53 (p = 0.14), or programmed death-ligand 1 (PD-L1, p = 0.27) expression. Conclusions: Non-smokers with LSCC are more likely to be younger at the time of diagnosis and have glottic tumors than smokers with LSCC. In TMA analysis of stage and age-matched specimens from smoker and non-smokers with LSCC, the pattern of expression for common molecular and immunologic markers is similar. Further, HPV does not appear to be a major causative etiology of LSCC in either smokers or non-smokers in our cohort of patients.

KW - HPV

KW - Immunohistochemistry

KW - Laryngeal cancer

KW - Squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=85058145700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058145700&partnerID=8YFLogxK

U2 - 10.1016/j.amjoto.2018.11.009

DO - 10.1016/j.amjoto.2018.11.009

M3 - Article

C2 - 30553600

AN - SCOPUS:85058145700

JO - American Journal of Otolaryngology - Head and Neck Medicine and Surgery

JF - American Journal of Otolaryngology - Head and Neck Medicine and Surgery

SN - 0196-0709

ER -